National Cancer Institute; Notice of Closed Meetings, 65990-65991 [2019-25984]
Download as PDF
<![CDATA[
65990
Federal Register / Vol. 84, No. 231 / Monday, December 2, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request NCI Genomic Data Commons
(GDC) Data Submission Request Form
(National Cancer Institute)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI) will
publish periodic summaries of propose
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Zhining Wang, Ph.D., Project
Officer, Center for Cancer Genomics
FOR FURTHER INFORMATION CONTACT:
Submission Request Form, 0925–0752,
Expiration Date 05/31/2020,
EXTENSION, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The purpose of the NCI
Genomic Data Commons (GDC) Data
Submission Request Form is to provide
a vehicle for investigators to request
submission of their cancer genomic data
into the GDC in support of data sharing.
The purpose is to also provide a
mechanism for the GDC Data
Submission Review Committee to
review and assess the data submission
request for applicability to the GDC
mission. The scope of the form involves
obtaining information from investigators
that: (1) Would like to submit data about
their study into the GDC, (2) are
affiliated with studies that adhere to
GDC data submission conditions. The
benefits of the collection are that it
provides the needed information for
investigators to understand the types of
studies and data that the GDC supports,
and that it provides a standard
mechanism for the GDC to assess
incoming data submission requests.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
50 hours.
(CCG), National Cancer Institute,
Building 31 Room 3A20, 31 Center
Drive, Bethesda, MD 20814 or call nontoll-free number 301–402–1892 or Email
your request, including your address to:
zhining.wang@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: NCI
Genomic Data Commons (GDC) Data
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Average time
per response
(in hours)
Total annual
burden hour
Investigator ......................................................................................................
200
1
15/60
50
Total ..........................................................................................................
........................
200
........................
50
Dated: November 20, 2019.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2019–25997 Filed 11–29–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Number of
responses per
respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
17:10 Nov 29, 2019
Jkt 250001
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–2:
SBIR Contract Review.
Date: January 15–16, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850 (Telephone
Conference Call).
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Contact Person: Shakeel Ahmad, Ph.D.,
Chief Research Technology and Contract
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W102,
Rockville, MD 20850, 240–276–6442,
ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project (P01) Review IV.
Date: January 16–17, 2020.
Time: 7:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Clifford W Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Bethesda, MD 20892–8329, 240–276–6343,
schweinfestcw@mail.nih.gov.
E:\FR\FM\02DEN1.SGM
02DEN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 84, No. 231 / Monday, December 2, 2019 / Notices
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–2: NCI
Clinical and Translational R21 and Omnibus
R03.
Date: January 30–31, 2020.
Time: 7:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville, MD
20850, 240–276–7286, salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–4:
Cloud-Based Software for the Cancer
Research Data Common.
Date: February 6, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology &
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Rockville, MD 20850, (240)
276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
F—Institutional Training and Education.
Date: February 24–25, 2020.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W234, Bethesda, MD 20892–9750, 240–276–
6368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Molecular and Cellular Analysis
Technologies.
Date: March 4–5, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center. Montgomery County
Conference Center Facility. 5701 Marinelli
Road. North Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology &
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Rockville, MD 20850, (240)
276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Participant
Engagement and Cancer Genome Sequencing
Centers.
VerDate Sep<11>2014
17:10 Nov 29, 2019
Jkt 250001
Date: March 17–18, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Shakeel Ahmad, Ph.D.,
Chief, Research Technology and Contract
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W102,
Rockville, MD 20850, 240–276–6442,
ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–5: NCI
Clinical and Translational R21 and Omnibus
R03 Review Meeting.
Date: March 26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W234, Bethesda, MD 20892–9750, 240–276–
6368, Stoicaa2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: November 25, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–25984 Filed 11–29–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on ‘‘Update on
Selected Topics in Asthma
Management 2020: A Report From the
National Asthma Education and
Prevention Program Coordinating
Committee (NAEPPCC) Expert Panel
Report 4 (EPR–4) Working Group’’
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Request for Information.
The Expert Panel Working
Group of the NHLBI National Asthma
Education and Prevention Program
Coordinating Committee (NAEPPCC) is
SUMMARY:
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
65991
soliciting comments and suggestions
from the public on ‘‘Update on Selected
Topics in Asthma Management 2020: A
Report from the Expert Panel Report-4
(EPR–4) Working Group.’’ This Request
for Information (RFI) invites the
scientific community, health
professionals, organizations, patient
communities, and the general public to
provide comments and suggestions,
including particular emphasis on the
feasibility, acceptability, and capacity
for implementation, of the proposed
recommendations and implementation
guidance. Responses to this RFI will be
used to update and revise the report as
necessary.
DATES: The NHLBI NAEPPCC RFI is
open for public comment for a period of
35 days. Comments must be received by
January 6, 2020 to ensure consideration.
After the public comment period has
closed, the comments received will be
considered in a timely manner by the
NHLBI NAEPPCC Expert Panel Working
Group.
ADDRESSES: Submissions may be
submitted electronically to [https://
www.epr4workgroup.org/
Asthma2020Guidelines] or by mail to
[Asthma2020Guidelines@westat.com].
FOR FURTHER INFORMATION CONTACT:
Questions about this request for
information should be directed to Susan
T. Shero, RN, MS, Executive Secretary,
NAEPPCC, National Heart, Lung, and
Blood Institute, National Institutes of
Health, 6701 Rockledge Blvd., Rm.
9182, Bethesda, MD 20892,
Asthma2020Guidelines@westat.com,
301–496–1051.
SUPPLEMENTARY INFORMATION:
The NHLBI NAEPPCC
In August 2015, the National Asthma
Education and Prevention Program
Coordinating Committee (NAEPPCC)
was chartered as a federal advisory
committee in accordance with 424B of
the Public Health Service Act, 42 U.S.C.
285b–7b, as amended. The committee is
governed by the provisions of the
Federal Advisory Committee Act
(FACA), as amended (5 U.S.C App.),
which sets forth standards for the
formation and use of advisory
committees. The NAEPPCC fulfills the
charges of 424B of the Public Health
Service Act, 42 U.S.C. 285b–7b, as
amended:
• Identify all Federal programs that
carry out asthma-related activities.
• Develop, in consultation with
appropriate federal agencies and
professional and voluntary health
organizations, a Federal plan for
responding to asthma.
E:\FR\FM\02DEN1.SGM
02DEN1
]]>Agencies
[Federal Register Volume 84, Number 231 (Monday, December 2, 2019)]
[Notices]
[Pages 65990-65991]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25984]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-2: SBIR Contract Review.
Date: January 15-16, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W102, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Shakeel Ahmad, Ph.D., Chief Research Technology
and Contract Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850, 240-276-6442, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Program Project (P01) Review IV.
Date: January 16-17, 2020.
Time: 7:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Clifford W Schweinfest, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W108, Bethesda, MD 20892-8329, 240-276-6343,
[email protected].
[[Page 65991]]
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-2: NCI Clinical and Translational R21 and Omnibus R03.
Date: January 30-31, 2020.
Time: 7:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, MD 20850, 240-276-7286, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-4: Cloud-Based Software for the Cancer Research Data
Common.
Date: February 6, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology & Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Rockville, MD 20850, (240) 276-5460,
[email protected].
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee F--Institutional Training and Education.
Date: February 24-25, 2020.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W234, Bethesda, MD 20892-9750, 240-276-6368,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Molecular and Cellular Analysis Technologies.
Date: March 4-5, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center.
Montgomery County Conference Center Facility. 5701 Marinelli Road.
North Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology & Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Rockville, MD 20850, (240) 276-5460,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Participant Engagement and Cancer Genome Sequencing Centers.
Date: March 17-18, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Shakeel Ahmad, Ph.D., Chief, Research Technology
and Contract Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850, 240-276-6442, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-5: NCI Clinical and Translational R21 and Omnibus R03
Review Meeting.
Date: March 26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W234, Bethesda, MD 20892-9750, 240-276-6368,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: November 25, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-25984 Filed 11-29-19; 8:45 am]
BILLING CODE 4140-01-P
